Quick Answer
DiaMedica Therapeutics Inc. reported Net Income of -$32.77 million for fiscal year 2025.
DiaMedica Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$32.77M | -34.0% |
| 2024 | -$24.44M | -26.1% |
| 2023 | -$19.38M | -41.7% |
| 2022 | -$13.68M | -0.6% |
| 2021 | -$13.59M | -10.6% |
| 2020 | -$12.29M | -15.4% |
| 2019 | -$10.65M | -85.7% |
| 2018 | -$5.73M | -34.6% |
| 2017 | -$4.26M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.62M | -37.4% | -12.0% |
| June 30, 2025 | -$7.70M | -50.4% | +0.1% |
| March 31, 2025 | -$7.71M | -49.6% | -22.8% |
| September 30, 2024 | -$6.27M | -40.3% | -22.6% |
| June 30, 2024 | -$5.12M | -14.3% | +0.6% |
| March 31, 2024 | -$5.15M | +2.3% | -15.2% |
| September 30, 2023 | -$4.47M | -46.2% | +0.1% |
| June 30, 2023 | -$4.48M | -33.3% | +15.1% |
- DiaMedica Therapeutics Inc. showed a decrease of -34.0% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, DiaMedica Therapeutics Inc.’s net income has declined by 669.2% (from -$4.26 million to -$32.77 million).
- The most recent figure is from DiaMedica Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: